Mochida Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3922800002
JPY
3,135.00
-5 (-0.16%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
29,464.00
32,502.00
28,354.00
26,631.00
24,428.00
29,635.00
25,689.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
29,464.00
32,502.00
28,354.00
26,631.00
24,428.00
29,635.00
25,689.00
Raw Material Cost
15,062.00
17,495.00
15,128.00
13,005.00
12,089.00
13,471.00
13,360.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
42.00
29.00
1.00
0.00
1.00
1.00
0.00
Selling and Distribution Expenses
8,608.00
8,766.00
8,317.00
8,265.00
8,529.00
8,740.00
8,279.00
Other Expenses
313.10
365.30
251.30
278.80
292.60
397.20
244.70
Total Expenditure (Excl Depreciation)
26,843.00
29,943.00
25,959.00
24,058.00
23,545.00
26,184.00
24,086.00
Operating Profit (PBDIT) excl Other Income
2621
2559
2395
2573
883
3451
1603
Other Income
268.00
642.00
3.00
211.00
-459.00
110.00
102.00
Operating Profit (PBDIT)
3,678.00
3,970.00
3,123.00
3,480.00
1,197.00
4,310.00
2,418.00
Interest
42.00
29.00
1.00
0.00
1.00
1.00
0.00
Exceptional Items
-24.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
14,402.00
15,007.00
13,226.00
13,626.00
12,339.00
16,164.00
12,329.00
Depreciation
789.00
769.00
725.00
696.00
773.00
749.00
713.00
Profit Before Tax
2,824.00
3,167.00
2,398.00
2,782.00
423.00
3,561.00
1,704.00
Tax
1,263.00
681.00
435.00
888.00
344.00
781.00
433.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,561.00
2,486.00
1,962.00
1,894.00
80.00
2,780.00
1,271.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1,561.00
2,486.00
1,962.00
1,894.00
80.00
2,780.00
1,271.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,561.00
2,486.00
1,962.00
1,894.00
80.00
2,780.00
1,271.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,40,326.00
1,37,431.00
1,35,206.00
1,31,152.00
1,30,694.00
1,30,316.00
1,29,106.00
Earnings per share (EPS)
44.03
70.13
55.35
53.43
2.26
78.42
35.85
Diluted Earnings per share
44.03
70.13
55.35
53.43
2.26
78.42
35.85
Operating Profit Margin (Excl OI)
8.9%
7.87%
8.45%
9.66%
3.61%
11.65%
6.24%
Gross Profit Margin
12.26%
12.11%
11.01%
13.06%
4.9%
14.54%
9.41%
PAT Margin
5.3%
7.65%
6.92%
7.11%
0.33%
9.38%
4.95%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2026 is 20.62% vs -0.97% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is 1,851.25% vs -22.33% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is 105.92% vs 117.61% in Mar 2025

stock-summary

Interest

YoY Growth in quarter ended Mar 2026 is 4,100.00% vs 0.00% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025

Compare Quarterly Results Of Mochida Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
29,464.00
69,645.00
-40,181.00
-57.69%
Other Operating Income
0.00
0.00
0.00
Total Operating income
29,464.00
69,645.00
-40,181.00
-57.69%
Raw Material Cost
15,062.00
45,662.00
-30,600.00
-67.01%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
42.00
580.00
-538.00
-92.76%
Selling and Distribution Expenses
8,608.00
20,372.00
-11,764.00
-57.75%
Other Expenses
313.10
-58.00
371.10
639.83%
Total Expenditure (Excl Depreciation)
26,843.00
66,034.00
-39,191.00
-59.35%
Operating Profit (PBDIT) excl Other Income
2,621.00
3,611.00
-990.00
-27.42%
Other Income
268.00
185.00
83.00
44.86%
Operating Profit (PBDIT)
3,678.00
9,847.00
-6,169.00
-62.65%
Interest
42.00
580.00
-538.00
-92.76%
Exceptional Items
-24.00
-14,000.00
13,976.00
99.83%
Gross Profit (PBDT)
14,402.00
23,983.00
-9,581.00
-39.95%
Depreciation
789.00
6,051.00
-5,262.00
-86.96%
Profit Before Tax
2,824.00
-10,785.00
13,609.00
126.18%
Tax
1,263.00
1,046.00
217.00
20.75%
Provisions and contingencies
0
0
0.00
Profit After Tax
1,561.00
-11,832.00
13,393.00
113.19%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
1,561.00
-11,832.00
13,393.00
113.19%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,561.00
-11,832.00
13,393.00
113.19%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
1,40,326.00
1,78,103.00
-37,777.00
-21.21%
Earnings per share (EPS)
44.03
-240.35
284.38
118.32%
Diluted Earnings per share
44.03
-240.35
284.38
118.32%
Operating Profit Margin (Excl OI)
8.90%
5.18%
0.00
3.72%
Gross Profit Margin
12.26%
-6.80%
0.00
19.06%
PAT Margin
5.30%
-16.99%
0.00
22.29%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 2,946.40 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -9.35% vs 14.63% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 20.62% vs -0.97% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 156.10 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -37.21% vs 26.71% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 1,851.25% vs -22.33% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 341.00 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 2.46% vs 6.67% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 105.92% vs 117.61% in Mar 2025

Quarterly - Interest
Interest 4.20 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 44.83% vs 2,800.00% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 4,100.00% vs 0.00% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 8.90%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025